The science, economics, and effectiveness of combination therapy for hepatitis C

Gut. 2000 Aug;47(2):159-61. doi: 10.1136/gut.47.2.159.
No abstract available

MeSH terms

  • Antiviral Agents / economics
  • Antiviral Agents / therapeutic use*
  • Cost-Benefit Analysis
  • Drug Therapy, Combination
  • Hepatitis C / drug therapy*
  • Hepatitis C / economics
  • Humans
  • Ribavirin / economics
  • Ribavirin / therapeutic use
  • Treatment Outcome

Substances

  • Antiviral Agents
  • Ribavirin